Therapeutic approach to hyperkalemia

Nephron

Volumn 92, Issue SUPPL. 1, 2002, Pages 33-40

  Kim, Ho Jung ^a,b   Han, Sang Woong ^a  

^a Hanyang University   (South Korea)

^b Hanyang University Guri Hospital   (South Korea)

Author keywords

Albuterol; Dialysis; Electrocardiogram; Insulin; Sodium bicarbonate

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMILORIDE; BICARBONATE; CALCIUM CHLORIDE; CAPTOPRIL; CYCLOSPORIN; DIGITALIS; DOCUSATE SODIUM; ENALAPRIL; FUROSEMIDE; GLUCONATE CALCIUM; GLUCOSE; GLYCYRRHETINIC ACID; HEPARIN; INSULIN; IRBESARTAN; LAXATIVE; LOSARTAN; NONSTEROID ANTIINFLAMMATORY AGENT; PENTAMIDINE; PHENOLPHTHALEIN; POLYSTYRENESULFONATE SODIUM; PROPRANOLOL; SALBUTAMOL; SORBITOL; SPIRONOLACTONE; TRIAMTERENE; TRIMETHOPRIM;

CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; ELECTROCARDIOGRAM; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; HYPERKALEMIA; INTESTINE NECROSIS; INTESTINE PERFORATION; LONG TERM CARE; NEBULIZER; NONHUMAN; PATHOPHYSIOLOGY; POTASSIUM BLOOD LEVEL; POTASSIUM EXCRETION; PRIORITY JOURNAL; RECURRENT DISEASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT PLANNING;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; CALCIUM; DIGESTIVE SYSTEM; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; HUMANS; HYPERKALEMIA; INSULIN; KIDNEY; POTASSIUM; RENAL DIALYSIS; SODIUM BICARBONATE;

EID: 0036970779     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065375     Document Type: Conference Paper

References (34)

1. Weiner ID, Wingo CS: Hyperkalemia: A potential silent killer. J Am Soc Nephrol 1998;9:1535-1543.
2. Dagher G, Vantyghem MC, Doise B, Lallau G, Racadot A, Lefebvre J: Altered erythrocyte cation permeability in familial pseudohyperkalemia. Clin Sci 1989;77:213-216.
3. Ifudu O, Markell MS, Friedman EA: Unrecognized pseudohyperkalemia as a cause of elevated potassium in patients with renal disease. Am J Nephrol 1992;12:102-104.
4. Martinez-Vea A, Bardaji A, Garcia C, Oliver JA: Severe hyperkalemia with minimal electrocardiographic manifestations. J Electrocardiogr 1999;32:45-49.
5. Szerlip HM, Weiss J, Singer I: Profound hyperkalemia without electrocardiographic manifestations. Am J Kidney Dis 1986;7:461-465.
6. Acker CG, Johnson JP, Palevsky PM, Greenberg A: Hyperkalemia in hospitalized patients: Causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 1998;158:917-924.
7. Greenberg A: Hyperkalemia: Treatment options. Semin Nephrol 1998;18:46-57.
8. DeFronzo RA, Smith JD: Clinical disorders of hyperkalemia; in Narins RG (ed): Clinical Disorders of Fluid and Electrolyte Metabolism, ed 5. New York, McGraw Hill, 1994, pp 697-754.
9. Clausen T, Hansen O: Active Na-K transport and the rate of ouabain binding: The effect of insulin and other stimuli on skeletal muscle and adipocytes. J Physiol (Lond) 1977;270:415-430.
10. Goguen JM, Halperin ML: Can insulin administration cause an acute metabolic acidosis in vivo? An experimental study in dogs. Diabetologia 1993;36:813-816.
11. Allon M, Copney C: Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int 1990;38:869-872.
12. Ljutic D, Rumboldt Z: Should glucose administered before, with, or after insulin, in the management of hyperkalemia? Ren Fail 1993;15:73-76.
13. Montoliu J, Revert L: Lethal hyperkalemia associated with severe hyperglycemia in diabetic patients with renal failure. Am J Kidney Dis 1985;5:47-48.
14. Bia MJ, Lu M, Tyler K, De Fronzo RA: Beta adrenergic control of extrarenal potassium disposal: A beta-2 mediated phenomenon. Nephron 1986;43:117-122.
15. Allon M, Dunlay R, Copkney C: Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Ann Intern Med 1989;110:426-429.
16. Liou HH, Chiang SS, Wu SC, Huang TP, Campese VM, Smogorzewski M, Yang WC: Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: Comparative study. Am J Kidney Dis 1994;23:266-271.
17. Ahmed J, Weisberg L: Hyperkalemia in dialysis patients. Semin Dial 2001;14:348-356.
18. Schwarz KC, Cohen BD, Lubash GD, Rubin AL: Severe acidosis and hyperpotassemia treated with sodium bicarbonate infusion. Circulation 1959;14:215-220.
19. Fraley DS, Adler S: Correction of hyperkalemia despite constant blood pH. Kidney Int 1977;12:354-360.
20. Iqbal Z, Friedman EA: Preferred therapy of hyperkalemia in renal insufficiency: Survey of nephrology training-program directors. N Engl J Med 1989;320:60-61.
21. Blumberg A, Weidmann P, Shaw S, Gnadinger M: Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med 1988;85:507-512.
22. Blumberg A, Weidmann P, Ferrari P: Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure. Kidney Int 1992;41:369-374.
23. Kim HJ: Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients. Nephron 1996;72:476-482.
24. Allon M: Hyperkalemia in end-stage renal disease: Mechanisms and management. J Am Soc Nephrol 1995;6:1134-1142.
25. Flatman JA, Clausen T: Combined effects of adrenaline on excitation-induced stimulation of the sodium potassium pump in rat soleus muscle. Nature 1979;281:580-581.
26. Allon M, Shanklin N: effect of bicarbonate administration on plasma potassium in dialysis patients: Interactions with insulin and albuterol. Am J Kidney Dis 1996;28:508-514.
27. Emmett M, Hootkins RE, Fine KD, Santa Ana CA, Porter JL, Fordtran JS: Effect of three laxatives and a cation exchange resin on fecal sodium and potassium excretion. Gastroenterology 1995;108:752-760.
28. Hou S, McElroy PA, Nootens J, Beach M: safety and efficacy of low-potassium dialysate. Am J Kidney Dis 1989;13:137-143.
29. Sherman RA, Hwang ER, Bernholc AS, Eisinger RP: Variability in potassium removal by hemodialysis. Am J Nephrol 1986;6:284-288.
30. Kamel KS, Ethier JH, Quaggin S, Levin A, Carlisle EJ, Halperin ML: Studies to determine the basis for hyperkalemia in recipients for a renal transplant who are treated with cyclosporine. J Am Soc Nephrol 1992;2:1279-1284.
31. Arrizabalaga P, Montoliu J, Martinez Vea A, Andreu L, Lopez Pedret J, Revert L: Increase in serum potassium caused by beta-2 adrenergic blockade in terminal renal failure: Absence of mediation by insulin or aldosterone. Proc Eur Dial Transplant Assoc 1983;20:572-576.
32. Martin RS, Panese S, Virginillo M, Litardo M, Gimenez M, Arrizurrieta E, Hayslett JP: Increased secretion of potassium in the rectum of man with chronic renal failure. Am J Kidney Dis 1986;8:105-110.
33. Gifford JD, Rutsky EA, Kirk KA, McDaniel HG: Control of serum potassium disposal in men with end-stage renal disease. Kidney Int 1989;35:90-94.
34. Serra A, Uehlinger DE, Ferrari P, Dick B, Frey BM, Frey FJ, Vogt B: Glycyrrhetinic acid decreases plasma potassium concentrations in patients with anuria. J Am Soc Nephrol 2002;13:191-196.